Topic
Patents
771 published works
SCC Blog
ePCT 4.18: Startups and small entities can now claim search-fee reduction more easily
By Shubhi
On 13 October 2026, the Indian Patent Office, through a public announcement, informed stakeholders that ePCT Version 4.18 introduces two important features for applicants designating India as the International Searching…
IP IQ
A “Genius” Button and a Costly Silence: Google’s Obviousness Challenge Comes Up Short
A friendly email about a prospective business partner’s prototype may not feel like patent evidence. Neither does a design team’s decision to use a similar mechanism. But in Google LLC…
The IPKat
[Guest Post] Dose of reality: The Supreme Court of Canada reconciles the ban on patenting medical treatment with patents on dosing regimens
The IPKat has received and is pleased to host this guest contribution from Katfriend Jenna Park:Dose of reality: The Supreme Court of Canada reconciles the ban on patenting medical treatment…
Gadgets, Gigabytes & Goodwill Blog
Trick or Claim? What a Pumpkin Patent Teaches Us About Method Claims
If you've ever tried to carve a pumpkin, you know it's not as easy as it seems. The knife gets stuck, one eye ends up bigger than the other, and…
NIPC Law
FRAND: Samsung Electronics v ZTE Corp.
By janelambertnipclaw-blogspot-com
Lord Justice MeadeAuthor: Judicial Office (England and Wales) Licence: OGL V.3.0, Source: Wikimedia Commons Jane LambertPatents Court (Mr Justice Meade) Samsung Electronics Co Ltd and another v ZTE Corporation and others…
P.I.S.S.D.
5 Reasons to Hire a Patent Attorney When Starting a Business
By Bob Kraft
When you launch a new business, protecting your intellectual property often feels like an afterthought compared to funding, hiring, and marketing. However, the decisions you make about patents in your…
The IPKat
Post-published clinical data does not always save you (T 0251/25, Empagliflozin)
Empagliflozin (Jardiance) is approved in the US for reducing the risk of cardiovascular death in adults with type 2 diabetes (T2D) and established cardiovascular disease, and in Europe for reducing…
The IPKat
Reformatio in peius survives a procedural violation (T 1168/24)
Sometimes patent law is about procedures and not inventions. The appeal in T 1168/24 related to the lipid nanoparticle (LNP) technology behind the COVID-19 vaccines, opposed by Merck and Moderna.…
The Brand Protection Blog
China’s New AI Judicial Guidance: Key IP Takeaways for Businesses
By Justin Davidson (HK), Mina Li
On 7 September 2026, China’s Supreme People's Court (SPC) took a significant step in shaping the legal landscape for artificial intelligence by issuing its Opinions of the Supreme People's Court…
Spicy IP
Ribociclib: Access to Medicine Collides with Patent, Price and Policy
In this co-authored post, Ambika and Rishabh break down the recent Kerala High Court ruling on government use of patented inventions under Section 100 and situate it in the broader…